Study of OLP-1002 Injections for Reducing Moderate to Severe Pain Due to Osteoarthritis in Hip and/or Knee Joint
Clinical trial NCT05216341 · COMPLETED
Trial details
- NCT number
- NCT05216341
- Sponsor
- OliPass Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-11
- Primary completion
- 2023-09-07
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.